Clinical Trials Logo

Filter by:
NCT ID: NCT04820894 Withdrawn - Clinical trials for Hematopoietic and Lymphoid Cell Neoplasm

Perception of Cure Among Patients With Metastatic Cancer

Start date: October 30, 2021
Phase:
Study type: Observational

This study collects information about perception of cure among patients with cancer that has spread to other places in the body (metastatic). This study aims to determine patients' perception (knowledge) before starting immunotherapy and if differences exist in understanding of treatment to stimulate or restore the ability of the body's immune (defense) system to fight infection and disease (immunotherapy) based on social and economic factors or on race/ethnicity.

NCT ID: NCT04818944 Withdrawn - Ischemic Stroke Clinical Trials

Clinical Trial to Evaluate the Safety of Continuous IV Tirofiban in Acute Ischemic Stroke

iTREMT
Start date: March 1, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

We will recruit men and non-pregnant women of any ethnic background between the age ≥ 18 and ≤ 90 years that have acute ischemic stroke and underwent Mechanical Thrombectomy (MT) with TICI 2b or 2b following MT. These subject's will be will be randomized to placebo vs. Tirofiban after consent is obtained. This will be administered via continuous IV starting within 60 minutes of MT procedure completion. At the end of the 24 hour continuous IV dosing period a CT angiography and CT perfusion (CTA/CTP) will be obtained. The rest of the subjects inpatient hospital stay will be done per standard of care. The subject's NIHSS and modified Rankin Score (mRS) will be assessed at 90 days.

NCT ID: NCT04817865 Withdrawn - Clinical trials for Urinary Tract Infections

Comparison of Pre-procedural PCR and Culture-based UTI Assessment Prior to Intravesical Botox Injection

Start date: August 15, 2020
Phase:
Study type: Observational

This study is a retrospective record review to determine whether a novel multiplex PCR assay can be utilized as a screening method for UTI in patients receiving Botox injection to treat overactive bladder (OAB).

NCT ID: NCT04816071 Withdrawn - Covid19 Clinical Trials

Essential Amino Acid Supplementation in Older Adult COVID-19 Patients

Start date: May 2021
Phase: Phase 2/Phase 3
Study type: Interventional

A 4-week treatment of essential amino acids or placebo to participants with: 1) negative COVID-19 test with exposure, or 2) positive COVID-19 test and no or mild symptoms. The study team will measure change in symptoms. Participants will complete symptom surveys for 4 weeks and once at 8 and 12 weeks as well as pre- and post-assessments.

NCT ID: NCT04813991 Withdrawn - Perioperative Pain Clinical Trials

Pain Control Without Opioids

Start date: March 15, 2022
Phase: Phase 3
Study type: Interventional

Adequate outpatient pain control after uncomplicated laparoscopic appendectomy or cholecystectomy can be achieved with minimal breakthrough drugs when used in combination with around the clock non-opioid medications.

NCT ID: NCT04811404 Withdrawn - Bipolar Disorder Clinical Trials

A PET Study With [11C]PBR-28 and an Experimental Medication, Ethyl Eicosapentaenoic Acid

Start date: March 19, 2021
Phase: Phase 4
Study type: Interventional

This pilot study will ask whether omega three fatty acids have an antidepressant effect in bipolar depression by decreasing brain inflammation.

NCT ID: NCT04810494 Withdrawn - Clinical trials for Postoperative Nausea and Vomiting

Intranasal Lidocaine for Prevention of Postoperative Nausea and Vomiting.

Start date: October 1, 2022
Phase: Phase 4
Study type: Interventional

Postoperative nausea and vomiting (PONV) are common and continue to be persistent problems following general anesthesia. Intranasal lidocaine has been used for the treatment of migraine. The theoretical basis for this effect of intranasal lidocaine on migraine relief is reported to be due to its action on the sodium receptors within the sphenopalatine ganglion. Although there is no reported association between PONV and migraines, injecting lidocaine within the sphenopalatine ganglion has proven to be effective in reducing PONV in endoscopic sinus surgery. The purpose of this study is to investigate the efficacy of intranasal 2% lidocaine in preventing PONV.

NCT ID: NCT04809649 Withdrawn - Coccidioidomycosis Clinical Trials

SUBA-Itraconazole Therapy for Coccidioidomycosis Refractory or Intolerant to Fluconazole

SITRIS
Start date: May 15, 2021
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine how safe, effective, and well tolerated a new investigational antifungal drug, SUBA-itraconazole, is for patients who have been previously treated with fluconazole and have had either an insufficient response to treatment with fluconazole or a negative reaction to fluconazole preventing their further treatment with it.

NCT ID: NCT04809116 Withdrawn - Clinical trials for Posttraumatic Stress Disorder

Pimavanserin for Insomnia in Veterans With Posttraumatic Stress Disorder: Proof of Concept

Start date: December 15, 2022
Phase: Phase 4
Study type: Interventional

This is a proof-of-concept, open-label trial of pimavanserin 34mg at bedtime for 6 weeks in Veterans with insomnia and Posttraumatic Stress Disorder.

NCT ID: NCT04808921 Withdrawn - Covid-19 Clinical Trials

Performance Evaluation of SARS-COV-2 (Covid-19) Antigen Rapid Test

Start date: January 9, 2021
Phase: N/A
Study type: Interventional

The SARS-CoV-2 Antigen Rapid Test is a bioassay intended for rapid point-of-care detection of the SARS-CoV-2 virus. Performance of the SARS-CoV-2 Antigen Rapid Test assay will be assessed by comparison to a reference method.